jRCT2021230026
Untitled Trial
A Multicenter, Randomized, Double blind, Placebo controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS 986278 in Participants With Idiopathic Pulmonary Fibrosis
Bristol Myers Squibb·Japan Registry Clinical TrialRecruiting
Study focus
- Disease/Condition
- Idiopathic Pulmonary Fibrosis
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Bristol Myers Squibb
- Location
- United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Other interstitial pulmonary diseases with fibrosisCystic fibrosis with pulmonary manifestationsCystic fibrosisGraphite fibrosis (of lung)Pulmonary heart disease, unspecified
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT2021230026
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT2021230026 through Pure Global AI's free database. This phase not specified trial is sponsored by Bristol Myers Squibb and is currently Recruiting. The study focuses on Idiopathic Pulmonary Fibrosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.